Daehwa Pharmaceutical Co., Ltd

DAEHWA was established on Jan. of 1984 and listed in KOSDAQ(Stock market) since 2002. We are running 3 R&D centers and 4 Manufacturing facilities with philosophy of Respecting life / Protection of environment / Advanced Technology that leads pharmaceutical industry. We are tries to contribute to the health and well-being of human race.*R&D Center - Pankyo R&D Center: Mainly research on DDS(Drug Delivery System)/Natural products - Central R&D Center: Mainly research on impovement of products(Formulation and others)- Hyangnam R&D Center: Mainly research on synthesizing of API and others *Manufacturing facility - 1st factory: Mainly manufacturing for oral formulations(Tab./ Cap./ ODF) and external agents as ointment, cream and gel- 2nd factory: Dedicated for manufacturing for TDDS(Transdermal drug delivery system) products as Patch, Plaster, Cataplasma - 3rd factory: Dedicated for anticancer as oral solution (Newly builted for DHP107 - world first oral paclitaxel solution)- Hyangnam Factory: Manufacturing for API and health supplementary and so on. Also, we are running 4subsidiaries company as below- DH Horim: Pharmaceutical wholesaler - Redox-Bio: Synthesizing of HA(Hyaluronic acid)/PDRN/Glutachione and related trading - S-Med: Medical information system contents service - C-Tri: R&D and pharmaceutical manufacturer focusing on Bio-products Among out products, most important product is world first oral paclitaxel solution DHP-107(Project name). This product would be get approval in Korea around 3Q of 2016 for Gastric cancer as first indication. This product adopt the our platform technology DHLASED(DaeHwa Lipid-bAsed Self-Emulsifying Drug delivery system) as first project. For more details and other business cooperation oppotunity, please kindly contact to below email address; crispaul@dhpharm.co.kr (Mr. Paul/Young-Sang Cho - Manager of Overseas Business Dept./ Business Development) Thanks and best regards,